Clinical Trial Update: Safety of Prolonged Administration of Triticum Monococcum in Celiac Disease [Phase 2]

View source ↗

Summary

Phase 2 trial assessing the safety of prolonged administration of Triticum monococcum in individuals with celiac disease; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• Triticum monococcum (Triticum monococcum)

Snippet

Sponsor: Università degli Studi di Brescia | Conditions: Celiac Disease | Phase 2 | Status: COMPLETED